Completed NCT00610441
This summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listed Why is this study shown? This study is directly about ADHD.
ADHD Drug i A study involving a medication or substance. From 18 Years to 50 Years
Countries
Sponsor Merck Sharp & Dohme LLC
Condition ADHD Completed NCT01081132
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Drug From 13 Years to 17 Years
Countries United States
Sponsor Shire
Condition ADHD Completed NCT01070394
This study is completed in the United States. It focuses on ADHD.
In New York Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 55 Years
Countries United States
Sponsor NYU Langone Health
Condition ADHD Completed NCT03203928
This summary needs review. Please check the official study record and contact the research team for details.
In New York Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 21 Years to 55 Years
Countries United States
Sponsor Columbia University
Condition ADHD Completed NCT01552902
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Drug From 13 Years to 17 Years
Countries United States, Canada, Germany, ...
Sponsor Shire
Condition ADHD Completed NCT01161719
This study is completed in the United States. It focuses on ADHD.
In Sacramento Why is this study shown? This study is directly about ADHD.
ADHD Behavioral From 6 Years to 14 Years
Countries United States
Sponsor University of California, Davis
Condition ADHD Completed NCT00716274
This study is completed in the United States. It focuses on ADHD.
In New Haven Why is this study shown? This study is directly about ADHD.
ADHD Drug From 10 Years to 16 Years
Countries United States
Sponsor Eli Lilly and Company
Condition ADHD Completed NCT01244490
This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.
Multiple locations, including San Diego Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 17 Years
Countries United States, France, Canada, ...
Sponsor Shire
Condition ADHD Completed NCT00735371
This study is completed in the United States. It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 13 Years to 17 Years
Countries United States
Sponsor Shire
Condition ADHD Completed NCT01239030
This study is completed in the United States. It is testing Methylphenidate HCl ER Capsules for ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 18 Years
Countries United States
Sponsor Rhodes Pharmaceuticals, L.P.
Condition ADHD Completed NCT03325881
This study is completed in the United States. 25 mg for ADHD.
Multiple locations, including Dothan Why is this study shown? This study is directly about ADHD.
ADHD Drug From 6 Years to 12 Years
Countries United States
Sponsor Shire
Condition ADHD Completed NCT01259492
This study is completed in the United States, in Belgium, in Colombia, .... It is testing methylphenidate Hydrochloride Extended Release for ADHD.
Multiple locations, including Little Rock Why is this study shown? This study is directly about ADHD.
ADHD Drug From 18 Years to 60 Years
Countries United States, Belgium, Colombia, ...
Sponsor Novartis Pharmaceuticals
Condition ADHD